Metabolic Function of a Suboptimal Transplanted Islet Mass in Nonhuman Primates on Rapamycin Monotherapy

Cell Transplantation

Volumn 21, Issue 6, 2012, Pages 1297-1304

  Soleimanpour, Scott A ^a,b   Hirshberg, Boaz ^a   Bunnell, David J ^a   Sumner, Anne E ^a   Ader, Marilyn ^c   Remaley, Alan T ^d   Rother, Kristina I ^a   Rickels, Michael R ^b   Harlan, David M ^a,e  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Islet transplantation; Metabolic function; Nonhuman primates

Indexed keywords

ARGININE; GLUCOSE; INSULIN; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; ENGRAFTMENT; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN SENSITIVITY; METABOLISM; MONOTHERAPY; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIMATE; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; ARGININE; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; GLUCAGON; GLUCOSE TOLERANCE TEST; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA FASCICULARIS; SIROLIMUS;

ORYCTOLAGUS CUNICULUS; PRIMATES;

EID: 84865497716     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X603620     Document Type: Article

References (34)

1. Bell, E.; Cao, X.; Moibi, J. A.; Greene, S. R.; Young, R.; Trucco, M.; Gao, Z.; Matschinsky, F. M.; Deng, S.; Markman, J. F.; Naji, A.; Wolf, B. A. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52(11):2731-2739; 2003.
2. Bergman, R. N. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38(12):1512-1527; 1989.
3. Carlsson, P. O.; Andersson, A.; Carlsson, C.; Hellerstrom, C.; Hoglund, E.; King, A.; Kallskog, O.; Liss, P.; Mattsson, G.; Olsson, R.; Palm, F.; Sandler, S.; Tyrberg, B.; Jansson, L. Engraftment and growth of transplanted pancreatic islets. Ups. J. Med. Sci. 105(2):107-123; 2000.
4. Cefalu, W. T.; Wang, Z. Q.; Bell-Farrow, A. D.; Collins, J.; Morgan, T.; Wagner, J. D. Caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): Metabolic, physiologic, and atherosclerotic measures from a 4-year intervention trial. J. Gerontol. A. Biol. Sci. Med. Sci. 59(10):1007-1014; 2004.
5. Desai, N. M.; Goss, J. A.; Deng, S.; Wolf, B. A.; Markmann, E.; Palanjian, M.; Shock, A. P.; Feliciano, S.; Brunicardi, F. C.; Barker, C. F.; Naji, A.; Markmann, J. F. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: Local immunosuppression or islet toxicity? Transplantation 76(11):1623-1625; 2003.
6. Faradji, R. N.; Froud, T.; Messinger, S.; Monroy, K.; Pileggi, A.; Mineo, D.; Tharavanij, T.; Mendez, A. J.; Ricordi, C.; Alejandro, R. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction. Cell Transplant. 18(10):1247-1259; 2009.
7. Gerich, J. E.; Lorenzi, M.; Bier, D. M.; Schneider, V.; Tsalikian, E.; Karam, J. H.; Forsham, P. H. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N. Engl. J. Med. 292(19): 985-989; 1975.
8. Hering, B. J.; Kandaswamy, R.; Ansite, J. D.; Eckman, P. M.; Nakano, M.; Sawada, T.; Matsumoto, I.; Ihm, S. H.; Zhang, H. J.; Parkey, J.; Hunter, D. W.; Sutherland, D. E. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293(7):830-835; 2005.
9. Hirsch, D.; Odorico, J.; Radke, N.; Hanson, M.; Danobeitia, J. S.; Hullett, D.; Alejandro, R.; Ricordi, C.; Fernandez, L. A. Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: preliminary results. Diabetes Obes. Metab. 12(11):994-1003; 2010.
10. Hirshberg, B.; Mog, S.; Patterson, N.; Leconte, J.; Harlan, D. M. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression. J. Clin. Endocrinol. Metab. 87(12):5424-5429; 2002.
11. Hirshberg, B.; Montgomery, S.; Wysoki, M. G.; Xu, H.; Tadaki, D.; Lee, J.; Hines, K.; Gaglia, J.; Patterson, N.; Leconte, J.; Hale, D.; Chang, R.; Kirk, A. D.; Harlan, D. M. Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. Diabetes 51(7):2135-2140; 2002.
12. Hirshberg, B.; Preston, E. H.; Xu, H.; Tal, M. G.; Neeman, Z.; Bunnell, D.; Soleimanpour, S.; Hale, D. A.; Kirk, A. D.; Harlan, D. M. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model. Transplantation 76(1):55-60; 2003.
13. Johnson, J. D.; Ao, Z.; Ao, P.; Li, H.; Dai, L.; He, Z.; Tee, M.; Potter, K. J.; Klimek, A. M.; Meloche, R. M.; Thompson, D. M.; Verchere, C. B.; Warnock, G. L. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant. 18(8):833-845; 2009.
14. Kahn, S. E.; Prigeon, R. L.; McCulloch, D. K.; Boyko, E. J.; Bergman, R. N.; Schwartz, M. W.; Neifing, J. L.; Ward, W. K.; Beard, J. C.; Palmer, J. P. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42(11):1663-1672; 1993.
15. Kandaswamy, R.; Melancon, J. K.; Dunn, T.; Tan, M.; Casingal, V.; Humar, A.; Payne, W. D.; Gruessner, R. W.; Dunn, D. L.; Najarian, J. S.; Sutherland, D. E.; Gillingham, K. J.; Matas, A. J. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis. Am. J. Transplant. 5(6): 1529-1536; 2005.
16. Kawamori, D.; Kurpad, A. J.; Hu, J.; Liew, C. W.; Shih, J. L.; Ford, E. L.; Herrera, P. L.; Polonsky, K. S.; McGuinness, O. P.; Kulkarni, R. N. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab. 9(4):350-361; 2009.
17. Kawamori, R.; Shichiri, M.; Kikuchi, M.; Yamasaki, Y.; Abe, H. The mechanism of exaggerated glucagon response to arginine in diabetes mellitus. Diabetes Res. Clin. Pract. 1(3):131-137; 1985.
18. Liu, Z.; Kim, W.; Chen, Z.; Shin, Y. K.; Carlson, O. D.; Fiori, J. L.; Xin, L.; Napora, J. K.; Short, R.; Odetunde, J. O.; Lao, Q.; Egan, J. M. Insulin and glucagon regulate pancreatic alpha-cell proliferation. PLoS One 6(1): e16096; 2011.
19. Lopez-Talavera, J. C.; Garcia-Ocana, A.; Sipula, I.; Takane, K. K.; Cozar-Castellano, I.; Stewart, A. F. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: Reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology 145(2): 467-474; 2004.
20. Luzi, L.; Perseghin, G.; Brendel, M. D.; Terruzzi, I.; Battezzati, A.; Eckhard, M.; Brandhorst, D.; Brandhorst, H.; Friemann, S.; Socci, C.; Di Carlo, V.; Piceni Sereni, L.; Benedini, S.; Secchi, A.; Pozza, G.; Bretzel, R. G. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 50(2):277-282; 2001.
21. Marcelli-Tourvieille, S.; Hubert, T.; Moerman, E.; Gmyr, V.; Kerr-Conte, J.; Nunes, B.; Dherbomez, M.; Vandewalle, B.; Pattou, F.; Vantyghem, M. C. In vivo and in vitro effect of sirolimus on insulin secretion. Transplantation 83(5):532-538; 2007.
22. Meier, J. J.; Hong-McAtee, I.; Galasso, R.; Veldhuis, J. D.; Moran, A.; Hering, B. J.; Butler, P. C. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes 55(8):2324-2332; 2006.
23. Menger, M. D.; Yamauchi, J.; Vollmar, B. Revascularization and microcirculation of freely grafted islets of Langerhans. World J. Surg. 25(4):509-515; 2001.
24. Montgomery, S. P.; Mog, S. R.; Xu, H.; Tadaki, D. K.; Hirshberg, B.; Berning, J. D.; Leconte, J.; Harlan, D. M.; Hale, D.; Kirk, A. D. Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. Am. J. Transplant. 2(4):381-385; 2002.
25. Pacini, G.; Bergman, R. N. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Programs Biomed. 23(2): 113-122; 1986.
26. Pechhold, K.; Zhu, X.; Harrison, V. S.; Lee, J.; Chakrabarty, S.; Koczwara, K.; Gavrilova, O.; Harlan, D. M. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes. Diabetes 58(5):1175-1184; 2009.
27. Rickels, M. R.; Naji, A.; Teff, K. L. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J. Clin. Endocrinol. Metab. 91(6):2138-2144; 2006.
28. Ricordi, C.; Lacy, P. E.; Finke, E. H.; Olack, B. J.; Scharp, D. W. Automated method for isolation of human pancreatic islets. Diabetes 37(4):413-420; 1988.
29. Ryan, E. A.; Lakey, J. R.; Paty, B. W.; Imes, S.; Korbutt, G. S.; Kneteman, N. M.; Bigam, D.; Rajotte, R. V.; Shapiro, A. M. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 51(7):2148-2157; 2002.
30. Soleimanpour, S. A.; Crutchlow, M. F.; Ferrari, A. M.; Raum, J. C.; Groff, D. N.; Rankin, M. M.; Liu, C.; De Leon, D. D.; Naji, A.; Kushner, J. A.; Stoffers, D. A. Calcineurin signaling regulates human islet {beta}-cell survival. J. Biol. Chem. 285(51):40050-40059; 2010.
31. Soliman, G. A.; Acosta-Jaquez, H. A.; Fingar, D. C. mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes. Lipids 45(12):1089-1100; 2010.
32. Tal, M. G.; Hirshberg, B.; Neeman, Z.; Bunnell, D.; Soleimanpour, S.; Bacher, J.; Patterson, N.; Chang, R.; Harlan, D. M. Induction of diabetes in nonhuman primates by means of temporary arterial embolization and selective arterial injection of streptozotocin. Radiology 230(1):163-168; 2004.
33. Teutonico, A.; Schena, P. F.; Di Paolo, S. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J. Am. Soc. Nephrol. 16(10):3128-3135; 2005.
34. Unger, R. H.; Aguilar-Parada, E.; Muller, W. A.; Eisentraut, A. M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J. Clin. Invest. 49(4):837-848; 1970.